Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for ORIC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 23.43M
March 31, 2026 21.20M
December 31, 2025 26.64M
September 30, 2025 24.27M
June 30, 2025 22.86M
March 31, 2025 23.12M
December 31, 2024 33.61M
September 30, 2024 28.08M
June 30, 2024 26.51M
March 31, 2024 22.14M
December 31, 2023 30.60M
September 30, 2023 26.92M
June 30, 2023 23.02M
March 31, 2023 23.84M
Date Value
December 31, 2022 28.01M
September 30, 2022 23.18M
June 30, 2022 22.81M
March 31, 2022 21.98M
December 31, 2021 29.08M
September 30, 2021 22.64M
June 30, 2021 9.904M
March 31, 2021 7.885M
December 31, 2020 9.221M
September 30, 2020 7.287M
June 30, 2020 6.278M
March 31, 2020 5.415M
December 31, 2019 6.119M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B
Anika Therapeutics, Inc. 46.19M
Savara, Inc. 48.48M
Vericel Corp. 132.82M

Total Liabilities (Quarterly) Related Metrics